Searched for
ABBOTT SHARE PRICE
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 24%When business updates start to come in or when some FMCG or auto companies indicate that things are not all good in the rural space, we may...23 Jun, 2026, 07.51 AM IST- Human urine becomes option for farmers in fertilizer supply crunchFrom chicken muck to human urine-based products and microbial solutions, growers are improvising to maintain crop yields. This shift, while...23 May, 2026, 10.31 AM IST
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...29 Apr, 2026, 02.22 PM IST
- Buy Abbott India, target price Rs 31,420: Axis SecuritiesAxis Securities recommends buying Abbott India Ltd. with a target price of Rs 31,420. The pharmaceutical company reported a 24% rise in fou...29 Oct, 2024, 09.31 AM IST
- Stock Radar: Abbott India records fresh high in August but pares gains; should you buy the dip?The pharma stock with a market capitalization of over Rs 50,000 crore on the BSE hit a record high of Rs 24,682 on 4 August 2023, after it ...08 Aug, 2023, 05.00 AM IST
- Chart Check: This pharma stock hits fresh 52-week high in December; likely to scale Rs 24,000For more than a decade, the stock has been taking support at a rising moving average followed by a breach of the intermediate falling trend...26 Dec, 2022, 11.01 AM IST
- Abbott India Q4 results: Net profit up 39% at Rs 211 croreRevenue from operations rose to Rs 1,255 crore in the period under review as compared with Rs 1,096 crore in the year-ago period, it added.17 May, 2022, 06.06 PM IST
- Abbott India Q2 results: Net profit up 6% to Rs 192 croreRevenue from operations stood at Rs 1,222.06 crore for the quarter under consideration.12 Nov, 2021, 01.57 PM IST
- Abbott India Q2 results: Net profit up 1% to Rs 181 croreRevenue from operations remained flat at Rs 1,054.85 crore during the quarter under review as compared with Rs 1,054.80 crore in the year-a...11 Nov, 2020, 05.11 PM IST
- Outperformer rating for Abbott India, target price Rs 18,130: CLSAThe lockdown will limit near-term growth, said CLSA, cutting FY21-FY22 EPS estimates by 9-11 per cent.10 Jun, 2020, 08.01 AM IST
- Buy Abbott India, Rs 18,069: ICICI SecuritiesAbbott India is one of the brokerages top picks in the pharma sector.07 Apr, 2020, 10.18 AM IST
- CLSA initiates coverage on Abbott India with buy ratingShares of Abbott India ended up 0.75 per cent at Rs 11,763 on Wednesday.14 Nov, 2019, 08.03 AM IST
- Share market update: 10 stocks hit 52-week highs on NSEBenchmark NSE Nifty index was trading 3.85 points down at 10,794.05.04 Sep, 2019, 10.35 AM IST
- Abbott to buy Latin American drugmaker CFR in $2.9 billion dealAbbott Lab would acquire Chile's CFR Pharma SA in a two-part, $2.9 bn deal, to double its branded generic drugs portfolio & expand in fast-...16 May, 2014, 07.00 PM IST
- Abbott Laboratories set to consolidate India operationsThe $39-bn pharma giant Abbott Labs will consolidate India operations under a new leadership, as part of a plan to tap operational synergie...28 Nov, 2012, 05.44 AM IST
- Abbott yet to reap benefits of Piramal buyThe purchase of Piramal Healthcare's domestic formulations biz by Abbott Lab has changed little on the ground for the foreign company even ...13 Jan, 2011, 04.37 AM IST
- Abbott India to buyback shares worth Rs 50.24 crDrug maker Abbott India on Friday said it will buyback shares worth up to Rs 50.24 cr from its shareholders at a price of Rs 630 per share.11 Jul, 2008, 07.48 PM IST
Load More
